A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the treatment – called trontinemab – could be the ...

Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter in patients with mild to moderate ...

A recent study reveals that daily walking can lower the risk of cognitive decline, particularly in those genetically prone to ...

New research builds on previous evidence that diet, certain brain training exercises and physical activity can delay the ...

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

The Pat Summitt Clinic is receiving a $1.25 million donation from the Pat Summitt Foundation to expand Alzheimer’s services and research.

An elderly British man suffering from Alzheimer's died of toxicity in the lungs after accidentally pouring white-coloured ...

Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...

Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...